$1.11 Billion is the total value of First Light Asset Management, LLC's 74 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RETA | Sell | REATA PHARMACEUTICALS INC | $144,283,494 | +84.1% | 1,586,928 | -23.1% | 12.99% | +78.6% |
| PRTA | Sell | PROTHENA CORP PLC | $73,246,313 | -20.8% | 1,511,168 | -1.6% | 6.60% | -23.2% |
| MODN | Sell | MODEL N INC | $62,042,435 | -33.0% | 1,853,673 | -18.8% | 5.59% | -35.0% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $26,282,587 | -50.0% | 688,206 | -25.4% | 2.37% | -51.5% |
| KRMD | Sell | KORU MEDICAL SYSTEMS INC | $26,127,358 | +15.5% | 6,191,317 | -2.3% | 2.35% | +12.0% |
| OMCL | Sell | OMNICELL COM | $19,566,973 | +12.8% | 333,509 | -3.1% | 1.76% | +9.4% |
| AXGN | Sell | AXOGEN INC | $18,343,357 | -22.5% | 1,941,096 | -18.2% | 1.65% | -24.8% |
| AXNX | Sell | AXONICS INC | $16,872,134 | -13.1% | 309,240 | -0.4% | 1.52% | -15.7% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $15,690,159 | -58.2% | 195,980 | -58.6% | 1.41% | -59.4% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $13,356,934 | +11.1% | 301,579 | -0.4% | 1.20% | +7.8% |
| Sell | MAXCYTE INC | $6,752,899 | -9.4% | 1,364,222 | -0.1% | 0.61% | -12.1% | |
| GMAB | Sell | GENMAB A/S | $6,042,544 | -11.0% | 160,025 | -0.1% | 0.54% | -13.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $5,978,510 | -52.2% | 61,482 | -49.2% | 0.54% | -53.7% |
| PFE | Sell | PFIZER INC | $5,775,123 | -20.5% | 141,547 | -0.2% | 0.52% | -22.8% |
| Sell | AKUMIN INC | $2,406,859 | -6.1% | 3,539,498 | -0.7% | 0.22% | -8.8% | |
| SLP | Sell | SIMULATIONS PLUS INC | $1,568,792 | +20.0% | 35,703 | -0.1% | 0.14% | +16.5% |
| IWO | Exit | ISHARES RUSSELL 2000 GROWTH ETF | $0 | – | -3,422 | -100.0% | -0.07% | – |
| BVS | Exit | BIOVENTUS INC | $0 | – | -1,376,536 | -100.0% | -0.33% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -137,077 | -100.0% | -1.45% | – |
| SPNE | Exit | SEASPINE HOLDINGS CORP | $0 | – | -6,877,650 | -100.0% | -5.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.